孟眸（成都）生物科技有限公司 Reviews, Salaries and Jobs | 孟眸生物 - Jobui

Find Clients More effective sales leads

Industry Library Company Library Job Library Nearby Companies Fortune 500 Batch Search

Bidding Industry Reports

Company Overview

Founded: 3年
Industry: 制药/生物工程
Full name: 孟眸（成都）生物科技有限公司。

Development Stage

Stage: Pre-A轮, 数千万人民币。

About the Company

[Summary] 退行性眼科疾病新药研发商

孟眸生物成立于2022年底，是一家专注于退行性眼科疾病新药研发的生物制药公司；公司致力于前沿生物技术的研究和应用，持续开发惠及广大眼科疾病患者的原创新药。孟眸生物坚持以科学为基础，持续投入探索疾病本质，高效开发基于基因治疗和干细胞技术的原创新药，进而改善广大眼病患者的生活质量。依托同仁眼科研究所的科学研究，以及创始人十余年的科学积累，孟眸生物当前管线包括通过利用体外重编程技术、诱导分化技术开发针对黄斑变性类疾病的干细胞疗法以及以AAV为载体的基因疗法，管线产品有望治疗或极大改善视网膜变性疾病。同时，孟眸生物正在建立多种视网膜疾病模型平台，包括病人iPSC分化的视网膜类器官平台、新型小鼠及灵长类动物疾病模型，为深入理解疾病机理和药物筛选与开发提供支撑。

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

孟眸生物 Financing History (2 rounds)

Manage

Pre-A轮

Capital Market Favor

Latest Financing Round

Date: ?
Amount: 数千万人民币
Investor: 未来新智，和谐超越，中关村...

孟眸生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Footprints / Contact / Network (latest company updates)

Official Website  

Company / Job Addresses

中国（四川）自由贸易试验区成都高新区新川路2222号D2栋1层1号 

Nearby Companies

新川广都中和

Business Registration

Provided by

Operating Status: 开业

Registered Capital: 153.7501万(元)

Legal Representative: 赵宁

Date Established:

Credit Code: 91510100MACC7XW95A

Registered Address: 中国（四川）自由贸易试验区成都高新区新川路2222号D2栋1层1号

Talent Demand Trend Analysis More

医药

生物科技/生物工程

干细胞

创新药

干细胞治疗

原研药

中 中文版 View this page in Chinese ›

Discover Great Companies, Discover Great Clients

成都公司名录  成都“制药/药业”公司名录  成都“医药”公司名录  成都“生物科技/生物工程”公司名录  成都“生物制品”公司名录  成都“干细胞”公司名录  附近的公司 

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates